Sunshine Biopharma Inc. (SBFMW) fundamentals score
In-licensing and Supply Agreements: Nora Pharma acquires the rights to import, market, sell and distribute the products in Canada by purchasing the drug dossiers from strategic partners. Nora Pharma then files the dossiers with Health Canada to obtain regulatory approval prior to marketing.
Pharmaceutical Preparations · Healthcare · Listed on NASDAQ
Overall: 4.8 out of 10, Weak long-term fundamentals
- Growth: 4.9/10
- Profitability: 2.9/10
- Financial health: 5.9/10
- Earnings quality: 9.5/10
- Valuation: 1.5/10
Scores are calculated from Sunshine Biopharma Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10